| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |